PremiumCompany AnnouncementsPhilogen S.p.A. Updates on Share Buyback Program Philogen S.p.A. Reports Strong Financial Position and Progress in Clinical Trials Philogen S.p.A. Approves 2024 Financials and Appoints New Board PremiumCompany AnnouncementsPhilogen Updates Share Buyback Program, Strengthening Market Position Philogen Publishes Shareholders’ Meeting Documentation for April 2025 Philogen S.p.A. Achieves Record Profits and Advances Cancer Therapy Pipeline PremiumCompany AnnouncementsPhilogen Advances Share Buyback Program Philogen SpA: Strategic Partnerships and Clinical Progress Drive Buy Rating Philogen Updates on Share Buyback Program